- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
ROSEN Law Firm Encourages PomDoctor Investors to Secure Counsel Before Deadline
Investors who purchased PomDoctor securities during the Class Period may be entitled to compensation.
Mar. 21, 2026 at 1:52pm
Got story updates? Submit your updates here. ›
The Rosen Law Firm, a global investor rights law firm, is reminding purchasers of securities of PomDoctor Ltd. (NASDAQ: POM) between October 9, 2025 and December 11, 2025, inclusive (the 'Class Period'), of the important April 7, 2026 lead plaintiff deadline in a securities class action lawsuit against the company.
Why it matters
The lawsuit alleges that PomDoctor was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals, as well as insiders and/or affiliates using offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign.
The details
Investors who purchased PomDoctor securities during the Class Period may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the PomDoctor class action, investors can go to the Rosen Law Firm's website or contact the firm for more information.
- The Class Period is from October 9, 2025 to December 11, 2025, inclusive.
- The lead plaintiff deadline is April 7, 2026.
The players
The Rosen Law Firm, P.A.
A global investor rights law firm that represents investors throughout the world, concentrating its practice in securities class actions and shareholder derivative litigation.
PomDoctor Ltd.
A company whose securities were purchased by investors during the Class Period, which is the subject of the securities class action lawsuit.
What they’re saying
“We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition.”
— Laurence Rosen, Founding Partner, The Rosen Law Firm
What’s next
Investors who wish to serve as lead plaintiff in the PomDoctor class action must move the Court no later than April 7, 2026.
The takeaway
This case highlights the importance for investors to be cautious of potential fraudulent stock promotion schemes and to seek qualified legal counsel when pursuing securities class action lawsuits.





